AU8526198A - Compounds with anti-ks and anti-hiv activity - Google Patents

Compounds with anti-ks and anti-hiv activity

Info

Publication number
AU8526198A
AU8526198A AU85261/98A AU8526198A AU8526198A AU 8526198 A AU8526198 A AU 8526198A AU 85261/98 A AU85261/98 A AU 85261/98A AU 8526198 A AU8526198 A AU 8526198A AU 8526198 A AU8526198 A AU 8526198A
Authority
AU
Australia
Prior art keywords
compounds
hiv activity
hiv
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85261/98A
Inventor
Tony Antakly
Ram M. Sairam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Montreal
Original Assignee
Universite de Montreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Montreal filed Critical Universite de Montreal
Publication of AU8526198A publication Critical patent/AU8526198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU85261/98A 1997-08-01 1998-07-30 Compounds with anti-ks and anti-hiv activity Abandoned AU8526198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5454397P 1997-08-01 1997-08-01
US60054543 1997-08-01
PCT/CA1998/000731 WO1999006438A2 (en) 1997-08-01 1998-07-30 Compounds with anti-ks and anti-hiv activity

Publications (1)

Publication Number Publication Date
AU8526198A true AU8526198A (en) 1999-02-22

Family

ID=21991839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85261/98A Abandoned AU8526198A (en) 1997-08-01 1998-07-30 Compounds with anti-ks and anti-hiv activity

Country Status (5)

Country Link
EP (1) EP1017722A2 (en)
CN (1) CN1271365A (en)
AU (1) AU8526198A (en)
CA (1) CA2299054A1 (en)
WO (1) WO1999006438A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) * 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
CN105698714B (en) * 2016-02-26 2018-09-25 江汉大学 Motion scan tunnel drift section and volume measurement device and its measurement method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides
US4973578A (en) * 1988-03-17 1990-11-27 Mayo Foundation For Medical Education And Research Synthetic peptides derived from the alpha-subunit of human lycoprotein hormones
DE69116563T3 (en) * 1990-09-21 2006-07-06 The Salk Institute For Biological Studies, La Jolla Process controlled by proto-oncogenic protein complex AP-1
US5723291A (en) * 1993-09-01 1998-03-03 The Regents Of The University Of California Methods for screening compounds for estrogenic activity
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
US5700781A (en) * 1994-10-04 1997-12-23 Harris; Pamela Jo Method for treating Kaposi's sarcoma and HIV infections
AU723646B2 (en) * 1995-10-16 2000-08-31 Laboratoires Serono Sa Use of human chorionic gonadotropin in the treatment of Kaposi's Sarcoma
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
WO1999006438A3 (en) 1999-04-08
CN1271365A (en) 2000-10-25
WO1999006438A2 (en) 1999-02-11
CA2299054A1 (en) 1999-02-11
EP1017722A2 (en) 2000-07-12

Similar Documents

Publication Publication Date Title
AU1407699A (en) Distributed architecture utility
AU9790198A (en) Compounds and methods
AU7908098A (en) Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones
AU1901299A (en) Modular and multifunctional structure
AU9781998A (en) Huchordin and uses thereof
AU3397195A (en) Construction elements
AU4298796A (en) An enzyme preparation with cellulytic activity
AU8279998A (en) Retained fastener
AU1172599A (en) Compounds with antitumor activity
AU4030697A (en) Proteins having telomerase activity
EP0903415A3 (en) Structure expansée
AU1155499A (en) Pesticidal combination
AU8695298A (en) Compounds and uses thereof
AU6006898A (en) Skin preparation
AU2660400A (en) Rantes-derived peptides with anti-hiv activity
AU6826898A (en) Pesticidal combination
AUPO309896A0 (en) Novel phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity
AU5763098A (en) Arylthio-dithiazindioxides and their use as pesticides
AU2862895A (en) Aryl, alkyl, alkenyl and alkynylmacrolides having immunosuppressive activity
AU8526198A (en) Compounds with anti-ks and anti-hiv activity
AU1878995A (en) Oligonucleotides with anti-epstein-barr virus activity
AU8155898A (en) Human preprotachykinin b
AU1645599A (en) Human matrilin-3
AU8693198A (en) Compounds and uses thereof
AU2801497A (en) Oligonucleotides with anti-epstein-barr virus activity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase